Cite
MLA Citation
Kathrin Heinrich et al.. “Gender-dependent survival benefit from first-line irinotecan in metastatic colorectal cancer. Subgroup analysis of a phase III trial (XELAVIRI-study, AIO-KRK-0110).” European journal of cancer, vol. 147, 2021, pp. 128–139. http://access.bl.uk/ark:/81055/vdc_100124047052.0x000030